Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05513625 · ClinicalTrials.gov registry record · Phase 1
Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir
A Phase 1 study, sponsored by AiCuris Anti-infective Cures.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT05513625 is a Phase 1 study that has completed, run by AiCuris Anti-infective Cures. The registered enrollment target is 16 participants.
The verdict
NCT05513625, a Phase 1 study, has completed, sponsored by AiCuris Anti-infective Cures.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
To investigate the effect of esomeprazole (ESO) on the pharmacokinetics of pritelivir (PTV), and to investigate the safety and tolerability of PTV.
Interventions
- DRUG Pritelivir
- DRUG ESO and pritelivir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2020-07-13 |
| Est. Completion | 2020-10-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05513625
The ClinicalTrials.gov registry entry for NCT05513625 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AiCuris Anti-infective Cures, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pritelivir is the first listed.
NCT05513625 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05513625 about?
NCT05513625 is a clinical study titled "Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir". To investigate the effect of esomeprazole (ESO) on the pharmacokinetics of pritelivir (PTV), and to investigate the safety and tolerability of PTV.
What is the current status of trial NCT05513625?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2020-07-13. Estimated completion is 2020-10-13.
What interventions are being tested in trial NCT05513625?
The interventions under investigation include: Pritelivir (DRUG), ESO and pritelivir (DRUG).
Who is sponsoring clinical trial NCT05513625?
This trial is sponsored by AiCuris Anti-infective Cures, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.